"False"
Skip to content
umu.se
For students
Library
For staff
Login
Students
All students must change their password since 7 May.
Edit
Edit content at umu.se
Svensk webbplats
Search
Menu
X close menu
Menu
Search
Search within:
Search within:
All
Education
Research
Staff
Student web
News
Other search services
Find courses and programmes
Library search tool
Search the legal framework
Main menu hidden.
Login
Students
All students must change their password since 7 May.
Edit
Edit content at umu.se
Svenska
Anne Andersson
Contact
E-mail
anne.andersson@umu.se
Phone
+46 90 785 78 87
Works at
Affiliation
Affiliated as physician at
Department of Diagnostics and Intervention
Section: Oncology
Location
27C, Målpunkt QC31, Norrlands universitetssjukhus
Umeå universitet, 901 85 Umeå
Publications
Publications
Research
Research
2024
Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40–74 at diagnosis in Sweden from 2008 to 2017
Journal of Medical Screening
Jonsson, Håkan; Andersson, Anne; Mao, Zheng; et al.
2024
Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40-74 years at diagnosis in Sweden 2008-2017
Acta Oncologica
, Medical Journals Sweden 2024, Vol. 63 : 552-556
Jonsson, Håkan; Andersson, Anne; Mao, Zheng; et al.
2024
Tailored dose-dense versus standard adjuvant chemotherapy for high-risk early breast cancer: end-of-study results of the randomized PANTHER trial
Journal of Clinical Oncology
, American Society of Clinical Oncology (ASCO) 2024, Vol. 42, (26) : 3077-3082
Matikas, Alexios; Möbus, Volker; Greil, Richard; et al.
2024
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the swedish phase ii randomized predix HER2 trial
Breast Cancer Research and Treatment
, Springer 2024, Vol. 204, (2) : 299-308
Zhu, Yajing; Zerdes, Ioannis; Matikas, Alexios; et al.
2023
Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study
Free Radical Biology & Medicine
, Elsevier 2023, Vol. 209 : 381-393
Hughes, David J.; Schomburg, Lutz; Jenab, Mazda; et al.
2023
Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk
Breast Cancer Research and Treatment
, Springer Nature 2023, Vol. 198, (2) : 361-368
Sund, Maria; Garmo, Hans; Andersson, Anne; et al.
2023
Receptor conversion and survival in breast cancer liver metastases
Breast Cancer Research
, BioMed Central (BMC) 2023, Vol. 25, (1)
Sundén, Marcus; Norgren, Sofia; Lundqvist, Robert; et al.
2021
High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma: is there a need for intervention in long-term survivors?
Upsala Journal of Medical Sciences
, Upsala Medical Society 2021, Vol. 126
Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; et al.
2021
Neoadjuvant trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in patients with ERBB2-positive breast cancer
JAMA Oncology
, American Medical Association (AMA) 2021, Vol. 7, (9) : 1360-1367
Hatschek, Thomas; Foukakis, Theodoros; Bjöhle, Judith; et al.
2020
Surgical treatment of breast cancer liver metastases: A nationwide registry-based case control study
European Journal of Surgical Oncology
, Elsevier 2020, Vol. 46, (6) : 1006-1012
Sundén, Marcus; Hermansson, Cecilia; Taflin, Helena; et al.
2019
Adherence to adjuvant endocrine therapy after breast cancer in Sweden 2008-2010: a nationwide survey
American Society of Clinical Oncology 2019
Andersson, Anne; von Wachenfeldt Väppling, Anna; de Jong, Anna; et al.
2019
Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard?
Journal of Clinical Oncology
, American Society of Clinical Oncology 2019, Vol. 37, (15) : 501-501
Bergh, Jonas C. S.; Andersson, Anne; Bjohle, Judith; et al.
2019
Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer.
Journal of Clinical Oncology
, American Society of Clinical Oncology 2019, Vol. 37, (15) : 583-583
Brandberg, Yvonne; Andersson, Anne; Bjohle, Judith; et al.
2017
Biverkningar vid antihormonell behandling påverkar följsamhet: Viktigt vara medveten om problemen för att motivera patienter att fullfölja behandlingen
Läkartidningen
, Läkartidningen Förlag 2017, Vol. 114, (7)
von Wachenfeldt, Anna; Andersson, Anne; Fornander, Tommy; et al.
2015
Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: a nested case-control study
PLOS ONE
, PLOS one 2015, Vol. 10, (10)
Clendenen, Tess V.; Ge, Wenzhen; Koenig, Karen L.; et al.
2015
Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study
International Journal of Cancer
, Vol. 136, (11) : 2640-2648
McKenzie, Fiona; Ferrari, Pietro; Freisling, Heinz; et al.
2015
Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC)
International Journal of Cancer
, Vol. 137, (4) : 940-948
Ricceri, Fulvio; Fasanelli, Francesca; Giraudo, Maria Teresa; et al.
2015
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study
Breast Cancer Research
, Vol. 17
Tikk, Kaja; Sookthai, Disorn; Fortner, Renee T.; et al.
2014
Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases
Cancer Epidemiology, Biomarkers and Prevention
, Vol. 23, (6) : 934-945
Ali, Alaa M. G.; Schmidt, Marjanka K.; Bolla, Manjeet K.; et al.
2014
Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study
International Journal of Cancer
, Vol. 135, (12) : 2887-2899
Emaus, Marleen J.; van Gils, Carla H.; Bakker, Marije F.; et al.
2014
Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status: A prospective study within the EPIC cohort
International Journal of Cancer
, Vol. 134, (11) : 2683-2690
Kaaks, Rudolf; Johnson, Theron; Tikk, Kaja; et al.
2014
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort
International Journal of Cancer
, Vol. 134, (8) : 1947-1957
Kaaks, Rudolf; Tikk, Kaja; Sookthai, Disorn; et al.
2014
Dietary fat intake and development of specific breast cancer subtypes
Journal of the National Cancer Institute
, Oxford University Press 2014, Vol. 106, (5) : dju068-
Sieri, Sabina; Chiodini, Paolo; Agnoli, Claudia; et al.
2014
Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort
Annals of Oncology
, Oxford University Press 2014, Vol. 25, (7) : 1422-1428
Tikk, Kaja; Sookthai, Disorn; Johnson, Theron; et al.
2013
Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: A nested case-control study
International Journal of Cancer
, Vol. 133, (7) : 1689-1700
Kühn, Tilman; Kaaks, Rudolf; Becker, Susen; et al.
2013
Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: A cohort study
International Journal of Cancer
, Wiley-Blackwell 2013, Vol. 132, (11) : 2619-2629
Ritte, Rebecca; Lukanova, Annekatrin; Tjonneland, Anne; et al.
2013
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study
BMC Cancer
, BioMed Central 2013, Vol. 13 : Article Number: 584-
Ritte, Rebecca; Tikk, Kaja; Lukanova, Annekatrin; et al.
2013
Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition
International Journal of Cancer
, Vol. 132, (7) : 1667-1678
Steindorf, Karen; Ritte, Rebecca; Eomois, Piia-Piret; et al.
2011
Long-term side effects after treatment of Hodgkin's lymphoma
Umeå University medical dissertations
, 1416
Andersson, Anne
2011
Long term risk of infections in Hodgkin lymphoma long-term survivors
British Journal of Haematology
, Vol. 154, (5) : 661-663
Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.
2009
Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors: retrospective cohort analyses and a concept for prospective intervention
International Journal of Cancer
, Vol. 124, (8) : 1914-1917
Andersson, Anne; Näslund, Ulf; Tavelin, Björn; et al.
2008
Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
British Journal of Cancer
, Vol. 98, (5) : 1001-1005
Andersson, Anne; Enblad, Gunilla; Tavelin, Björn; et al.
Cardiovascular side effects following treatment of Hodgkin’s lymphoma: comorbidity factors and a strategy for intervention
Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.
View publications in DiVA
Research groups
Group member
Håkan Jonsson lab
Research projects
1 December 2023 until 31 December 2028
Biomarker for early detection of breast cancer
+ Show more
- Show less